Plavix Does Not Cause Cough
Plavix (clopidogrel) is not associated with causing cough. This is an antiplatelet medication that works through a completely different mechanism than drugs known to cause cough, and cough is not listed as an adverse effect in the FDA drug labeling 1.
Why This Question Arises
The confusion likely stems from the well-established association between ACE inhibitors and chronic cough, which is a common and well-documented side effect. However, clopidogrel operates through an entirely different pharmacologic pathway and does not share this adverse effect.
Key Distinguishing Features:
ACE Inhibitor-Induced Cough:
- Occurs in 5-35% of patients taking ACE inhibitors 2
- Mechanism involves accumulation of bradykinin and substance P in airways 2
- Typically develops within hours to months after starting therapy 2
- Resolves within 1-4 weeks (occasionally up to 3 months) after discontinuation 2
- More common in women, nonsmokers, and persons of Chinese origin 2
Plavix (Clopidogrel):
- Works as a platelet aggregation inhibitor, not through the ACE pathway
- FDA labeling lists bleeding complications as the primary concern, not respiratory symptoms 1
- The only respiratory-related warning in the drug label is to "call your doctor right away if you cough up blood or blood clots" - this refers to bleeding complications, not cough as a side effect 1
What the Evidence Shows
The comprehensive ACCP guidelines on drug-induced cough specifically list medications that cause chronic dry cough: angiotensin-converting enzyme inhibitors, inhaled medications, mycophenolate mofetil, nitrofurantoin, propofol, and beta-blockers 3. Notably absent from this list is clopidogrel or any antiplatelet agents.
Clinical Implications:
If a patient on Plavix develops a cough, investigate other causes:
- ACE inhibitors (if taking concurrently) - most likely culprit if on combination therapy
- Upper airway cough syndrome (postnasal drip)
- Asthma or bronchospasm
- Gastroesophageal reflux disease
- Postinfectious causes
- Other medications the patient may be taking
Common Pitfall to Avoid
Do not discontinue Plavix if a patient develops a cough without thoroughly investigating other causes. Premature discontinuation of clopidogrel, particularly after coronary stent placement, significantly increases the risk of stent thrombosis, myocardial infarction, and death 1, 4. The actual adverse effects of Plavix include bleeding complications (bruising, nosebleeds, prolonged bleeding) and rare hypersensitivity reactions (typically rash, occurring in up to 6% of patients) 5, 6, 4.
If the patient is taking both an ACE inhibitor and Plavix and develops a cough, the ACE inhibitor is the likely culprit 2. The appropriate action is to discontinue the ACE inhibitor and consider switching to an angiotensin receptor blocker (ARB), which has a similar incidence of cough to placebo 2.